Welcome to the Nevada Board of Pharmacy website

Beware: Scammers Impersonating Pharmacy Board Personnel

Please beware of scammers impersonating Board personnel to extort money or steal your personal information.  

The Board continues to receive reports of calls threatening legal action if an exorbitant fine is not paid immediately over the phone. Callers identify themselves as Board of Pharmacy personnel and instruct their victims to pay a "fine" via wire transfer to avoid arrest, prosecution, imprisonment, and license suspension or revocation. Some calls may appear with the Board's phone number (775-850-1440).    

Board personnel will never contact healthcare providers or members of the public to demand money or any other form of payment, and will never request personal or other sensitive information.    

Anyone receiving a "License Suspension Notice" or any other purported Board document via fax, or a telephone call from a person purporting to be a Board representative demanding money, should refuse the demand and report the incident using the Board's online complaint form. If you are unsure whether an individual claiming to be a Board representative is legitimate or have questions about any correspondence you receive, call the Board office at 775-850-1440.  

Individual Registrant and Business Licensee Disclosure Requirements

Nevada State Board of Pharmacy Licensees:

 In 2022, NAC 639.229 was adopted. This law requires:

1. The holder of any certificate, license or permit issued by the Board to report to the Board:
2. 1. Any conviction not later than 30 days after the conviction and provide any documentation of the conviction requested by the Executive Secretary;
   2. Any administrative action taken against the holder by any professional licensing board or any state or federal agency not later than 30 days after the final disposition of the administrative action and provide any documentation of the administrative action requested by the Executive Secretary; or
   3. The surrender of any registration issued by the Attorney General of the United States pursuant to 21 U.S.C. § 823 immediately upon the surrender and provide any documentation of the surrender requested by the Executive Secretary.
    
3. If a holder of a certificate, license or permit issued by the Board reports a conviction or an administrative action pursuant to subsection 1, the Executive Secretary may require the holder to appear personally before the Board before the renewal of his or her certificate, license or permit.
4. For the purposes of this section, the term "conviction" means a conviction for any crime, other than a misdemeanor traffic violation that does not involve the use of alcohol or a controlled substance, and includes, without limitation, a:

The information above, pursuant to section 1 of NAC 639.229, must be reported to the Board on this form and emailed to teambc@pharmacy.nv.gov.

INVITING PUBLIC COMMENT ON PROPOSED REGULATION R113-24

The Nevada State Board of Pharmacy (Board) is inviting members of the public, including affected businesses and other interested persons, to comment on proposed regulation R113-24. This proposed regulation establishes requirements governing the staffing of certain pharmacies and the supervision of pharmaceutical technicians and pharmaceutical technicians in training.    

Persons wishing to comment upon the proposed regulation may appear at the scheduled January 16, 2025, public hearing, may appear at any regularly-scheduled meeting of the Board, or may address their comments, data, views, or arguments, in written form, to teambc@pharmacy.nv.gov.

A copy of the Notice of Public Hearing for proposed regulation R113-24 is available here. 

A schedule of all Board meetings with copies of the Public Notice and Agenda is available here. The Board takes public comment at the beginning and end of each day of a meeting.  

This invitation for public comment is in conformance with NRS 233B.066.

INVITING PUBLIC COMMENT ON NEVADA STATE BOARD OF PHARMACY’S LANGUAGE ACCESS PLAN

Nevada Revised Statute Chapter 232 (NRS 232.0081) and federal guidance on Title VI address the barriers persons with limited English proficiency face in accessing governmental programs and services. The Nevada State Board of Pharmacy (Board) is inviting members of the public to comment on the Board's Language Access Plan.  

Persons wishing to comment upon the draft Language Access Plan may appear at any regularly scheduled meeting of the Board to provide public comment or may address their comments in written form to teambc@pharmacy.nv.gov.

A schedule of all Board meetings is available here. The Board takes public comment at the beginning and end of each day of a meeting.  Comments will be taken on the draft Language Access Plan until March 31, 2025.

This invitation for public comment is in conformance with NRS 233B.066.

To view the Language Access Plan, please click link here.

Removal of DATA Waiver Requirement for Opioid Use Disorder Prescriptions

Removal of DATA Waiver Requirement for Opioid Use Disorder Prescriptions

ArrayRx

Nevada has joined other states to make the drug discount card program ArrayRx available to consumers: more info available at https://gov.nv.gov/layouts/full_page.aspx?id=366058.

ArrayRx FAQs: https://gov.nv.gov/uploadedFiles/govnewnvgov/Content/News/Press/2022attachments/ArrayRX_English.pdf

SB 190 and SB 325

Information on SB 190 regarding self-administered Hormonal Contraceptives dispensed without a prescription.  

Information on SB 325 regarding pharmacist authorization to prescribe, dispense, and administer drugs to prevent the acquisition of Human Immunodeficiency Virus (HIV) and to perform certain tests.  

Electronic Prescribing Mandate for Controlled Substances

NRS 639.23535 requires that all controlled substance prescriptions MUST be transmitted to a pharmacy by electronic prescribing (“e-prescribing”). While NRS 639.23535 took effect January 1, 2021, the Nevada State Board of Pharmacy (Board) provided an exemption for practitioners by regulation; see https://www.leg.state.nv.us/Register/2020Register/R083-20AP.pdf. The Law mandated that this exemption expires on December 31, 2021.      

    
Starting January 1, 2022, all controlled substance prescriptions MUST be transmitted to a pharmacy by electronic prescribing. The requirements do not apply to a prescription:  

    
a) Issued by a veterinarian;
b) Issued under circumstances where:
    1. Electronic transmission is unavailable due to technologic or electronic failure; or
    2. The drug will be dispensed at a pharmacy located outside of this State;
c) Issued by a practitioner who will also dispense the drug;
d) For which electronic prescribing is prohibited by federal law;
e) Issued pursuant to a protocol for research; or
f) Issued under circumstances in which the practitioner determines that:
    1. The patient is unable to obtain the drug in a timely manner if the prescription is given by electronic transmission; and
    2. Delay will adversely affect the patient’s medical condition. 

Pharmacists are NOT required to verify that a controlled substance prescription submitted by method other than e-prescribing meets one of the above exceptions. NRS 639.23535(4).  

 Pharmacists MAY NOT require a practitioner to verify that a controlled substance prescription submitted by a method other than e-prescribing meets one of the above exceptions. NRS 639.23535(4).   

A practitioner MUST utilize an approved e-prescribing software listed  HERE to transmit controlled substance prescriptions to a pharmacy. E-prescribing software not on the approved list MUST be approved by the Board before a practitioner may utilize that software. See NAC 639.7102 and the application located at  https://bop.nv.gov/Resources/FAQ/Electronic_Prescriptions_FAQ/.   

Frequently asked questions about the e-prescribing mandate are answered at the following https://bop.nv.gov/uploadedFiles/bopnvgov/content/Resources/ALL/FREQUENTLY%20ASKED%20QUESTIONS%20E-PRESCRIBE.pdf .   

COVID-19:

COVID-19 Response Efforts 

For more information on the state’s efforts to address coronavirus, visit https://dpbh.nv.gov/coronavirus/.

The Nevada State Board of Pharmacy Mission Statement:

In regulating the practice of pharmacy, The Nevada State Board of Pharmacy has a duty to carry out and enforce the provisions of Nevada law to protect the health, safety and welfare of the public.

Attention:

The Reno Board Office has relocated to 985 Damonte Ranch Pkwy Ste 206, Reno, NV, 89521.

Certificates are being emailed as they are processed. We no longer mail physical certificates. If you renewed online you may log back into your dashboard to reprint your certificate. Below is a link to log into your dashboard.

https://online.nvbop.org/

SB539

•  SB539 Survey 
•  SB539 Drug Transparency Draft Regulations 
•  Small Business Impact Survey 

Guidelines for the Safe Prescribing of a Controlled Substance for Pain

Current Nevada Law requires prescribers to obtain informed consent from patients regarding the potential risks of treatment using a controlled substance.  On September 23, 2014, the National Transportation Safety Board safety study, Drug Use Trends in Aviation: Assessing the Risk of Pilot Impairment, issued Safety Recommendation I-14-1 that prescribers of controlled substances for pain:

[D]iscuss with patients the effect their medical condition and medication use may have on their ability to safely operate a vehicle in any mode of transportation.

Prescribing practitioners should conform to Safety Recommendation I-14-1 when issuing prescriptions for controlled substances to Nevada patients in accordance with the provisions of NRS 639.23507 and 639.2391 to 639.23916, inclusive, and all applicable regulations.  See, e.g., NAC 630.187.

Funding

The Nevada State Board of Pharmacy is funded from license fees collected from our licensees. The Nevada State Board of Pharmacy does not receive funds from the State General Fund.